Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy - Chen, Hsing-Wu; Kuo, Yao-Wen; Chen, Chung-Yu; Chang, Chin-Hao; Wang, Su-Mei; Chien, Ying-Chun; Lu, Wei-Chen; Chen, Jo-Pai; Chang, Cheng-Yu; Wei, Yu-Feng; Chang, Shih-Chieh; Shu, Chin-Chung; et al. (The oncologist (Dayton, Ohio), 2024)
Keywords: Cancer; Cancer therapies; Care and treatment; Complications and side effects; Drug therapy; Female; Humans; Immune Checkpoint Inhibitors - adverse effects; Immunotherapy; Lung cancer; Lung Neoplasms - drug therapy; Male; Original; Prospective Studies; Retrospective Studies; Risk factors; Tuberculosis; Tuberculosis - chemically induced; Tuberculosis - drug therapy; Tuberculosis - epidemiology; China; latent tuberculosis infection; tuberculosis; immune checkpoint inhibitors